All Stories

Invivyd tweaks COVID prophylactic playbook, teaming wit...

Invivyd has teamed up with professional football coach Jim Harbaugh to tackle CO...

Eli Lilly logs massive Q4 revenue jump—but it's not jus...

Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli...

Fierce Pharma Asia—China troubles at Merck, AZ; Astella...

Merck & Co. and AstraZeneca suffered notable losses in China during the fourth q...

Regeneron tangles with Sanofi over commercial transpare...

In a lawsuit that received little attention toward the end of last year, Regener...

Don't call it a comeback: Pfizer returns to Super Bowl ...

Last year marked the first time in Pfizer’s 175-year history that the drugmaker ...

Roche details Gazyva's positive data en route to key lu...

Roche has detailed results of a phase 3 trial of its blood cancer drug Gazyva in...

J&J CEO broke a stalemate and facilitated the $14.6B In...

Johnson & Johnson's proposed $14.6 billion purchase of Intra-Cellular Therapies ...

Looking ahead at the most anticipated drug launches of ...

This week on "The Top Line," we dig into the 10 biggest potential drug launches ...

How ViiV Healthcare plans to 'show up even better' in t...

Since 1999, Feb. 7 has marked National Black HIV/AIDS Awareness Day, drawing att...

Bain throws down $3.3B to acquire Japan's Mitsubishi Ta...

Bain Capital is laying out 510 billion Japanese yen ($3.3 billion) to acquire Mi...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.